Literature DB >> 18525484

Lumbar stenosis and systemic diseases: is there any relevance?

Raphael Lotan1, Amir Oron, Yoram Anekstein, Ehud Shalmon, Yigal Mirovsky.   

Abstract

STUDY
DESIGN: A retrospective study of spinal stenosis patients admitted to Assaf Harofeh Medical Center Orthopedic Departments.
OBJECTIVE: To assess any correlation between systemic disease and spinal stenosis. SUMMARY OF BACKGROUND DATA: Lumbar stenosis is a common spinal disease with various etiologies. No findings have been reported correlating spinal stenosis incidence with background diseases, although diabetes mellitus (DM) has been found to play a role in intervertebral disc degeneration and spondylolisthesis.
METHODS: Hospitalization records of patients with spinal stenosis admitted to Assaf Harofeh Medical Center Orthopedic Departments between 1984 and 1993 were checked for background diseases, age, and sex. The data collected were statistically evaluated for any correlation between spinal stenosis and chronic diseases and compared with the data published by the "Israeli Bureau of Statistics" and Israel's largest Health Maintenance Organization's chronic disease survey.
RESULTS: Of 537 patients with spinal stenosis 57% (308) were males and (229) 43% females with an average age of 60+/-14 years. Diseases occurring with a high incidence were hypertension (HTN)-23.2% (compared with 7.8% in the general population), DM-13.6% (5.9%), ischemic heart disease (IHD)-11.9%, and hyperlipidemia-4.4%. Patients with spinal stenosis had no significant age and sex distribution difference compared with the general population and no such difference was found for patients suffering from HTN, IHD, or DM. Isolating the effect of DM on HTN and IHD revealed that HTN was a primary disease whereas IHD was secondary to DM with significant statistical validation (P=0.003).
CONCLUSIONS: To the best of our knowledge this is the first study linking spinal stenosis and DM or HTN. It was found that chronic diseases do not alter the natural age and sex distribution of spinal stenosis. The major question remaining concerns the biologic mechanism linking spinal stenosis and DM or HTN.

Entities:  

Mesh:

Year:  2008        PMID: 18525484     DOI: 10.1097/BSD.0b013e31813707af

Source DB:  PubMed          Journal:  J Spinal Disord Tech        ISSN: 1536-0652


  26 in total

1.  Alterations in intervertebral disc composition, matrix homeostasis and biomechanical behavior in the UCD-T2DM rat model of type 2 diabetes.

Authors:  Aaron J Fields; Britta Berg-Johansen; Lionel N Metz; Stephanie Miller; Brandan La; Ellen C Liebenberg; Dezba G Coughlin; James L Graham; Kimber L Stanhope; Peter J Havel; Jeffrey C Lotz
Journal:  J Orthop Res       Date:  2015-03-02       Impact factor: 3.494

2.  MR imaging assessment of lumbar intervertebral disk degeneration and age-related changes: apparent diffusion coefficient versus T2 quantitation.

Authors:  G Niu; J Yang; R Wang; S Dang; E X Wu; Y Guo
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-28       Impact factor: 3.825

3.  Impact of chronic hyperlipidemia on perioperative complications in patients undergoing lumbar fusion: a propensity score matching analysis.

Authors:  Mohamed Kamal Mesregah; Paul Mgbam; Zoe Fresquez; Jeffrey C Wang; Zorica Buser
Journal:  Eur Spine J       Date:  2022-08-06       Impact factor: 2.721

4.  Impact of lumbar spinal stenosis on metabolic syndrome incidence in community-dwelling adults in Aizu cohort study (LOHAS).

Authors:  Rei Ono; Misa Takegami; Yosuke Yamamoto; Shin Yamazaki; Koji Otani; Miho Sekiguchi; Shin-Ichi Konno; Shin-Ichi Kikuchi; Shunichi Fukuhara
Journal:  Sci Rep       Date:  2022-07-04       Impact factor: 4.996

5.  Dose- and time-dependent effect of high glucose concentration on viability of notochordal cells and expression of matrix degrading and fibrotic enzymes.

Authors:  Eun-Young Park; Jong-Beon Park
Journal:  Int Orthop       Date:  2013-03-16       Impact factor: 3.075

6.  Diabetes mellitus is associated with increased elastin fiber loss in ligamentum flavum of patients with lumbar spinal canal stenosis: results of a pilot histological study.

Authors:  Shai Shemesh; Eliezer Sidon; Efrat Kaisler; Dimitry Sheinis; Steven Velkes; Nissim Ohana; Dafna Benayahu
Journal:  Eur Spine J       Date:  2017-10-04       Impact factor: 3.134

7.  An overview of the identification and management of the metabolic syndrome in chiropractic practice.

Authors:  David R Seaman; Adam D Palombo
Journal:  J Chiropr Med       Date:  2014-09

8.  Body mass index and musculoskeletal pain: is there a connection?

Authors:  David R Seaman
Journal:  Chiropr Man Therap       Date:  2013-05-20

9.  Diabetes Mellitus and the Development of Lumbar Canal Stenosis: Is There Any Relevance?

Authors:  Ghanshyam Kakadiya; Kalpesh Saindane; Yogesh Soni; Kushal Gohil; Akash Shakya; Mohhamad Umair Attar
Journal:  Asian Spine J       Date:  2021-05-07

10.  Combined anti-inflammatory and anti-AGE drug treatments have a protective effect on intervertebral discs in mice with diabetes.

Authors:  Svenja Illien-Junger; Fabrizio Grosjean; Damien M Laudier; Helen Vlassara; Gary E Striker; James C Iatridis
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.